US Taxpayers Funded Research Giving Chinese Entities Over 1,000 Patents
Recent reports indicate that U.S. government agencies have inadvertently funded the development of over 1,000 patents held by China-based entities, contributing to significant advancements in strategic fields such as semiconductors, biotechnology, and pharmaceuticals. These patents have arisen over a decade, supported partially by funding from agencies like the Department of Defense, the Department of Energy, and NASA, among others. The funding raises concerns about national security, particularly regarding the U.S.-China Science and Technology Agreement, which has faced criticism for potentially benefitting China in military advancements. The agreement was set to expire recently and has undergone multiple extensions, raising further scrutiny around its implications for U.S. interests. Lawmakers underscore the alarming nature of this funding, highlighting almost 100 patents associated with the Department of Defense itself. However, the specifics of the projects related to these patents remain unclear.
Various U.S. government agencies have funded research for more than a decade that contributed to the creation of 1,020 U.S. patents for China-based entities, Reuters reported on Thursday.
The patents were granted in fields such as semiconductors, chemical engineering, nanotechnology and biotechnology, and all were funded at least in part by the U.S. and one China-based investor, according to Reuters. The revelations come alongside debates over whether the U.S. should withdraw from the U.S.-China Science and Technology Agreement, a bilateral research deal between the two countries that has fallen under some criticism for allegedly giving too much benefit to China.
“It’s alarming that U.S. taxpayers have unwittingly funded over 1,000 patents claimed by Chinese entities, with the Department of Defense accounting for nearly 100 of these patents,” Michigan Republican Rep. John Moolenar, chairman of the House Select Committee on the Chinese Communist Party, told Reuters.
Among the patents listed were 197 in the pharmaceutical sector and 154 in bio-technologies, which are both highly strategic fields for both the U.S. and China, according to patent data reviewed by Reuters. It was not clear whether the patents were d by U.S. entities or other individuals.
The funding was provided by agencies including the Department of Defense, the Department of Energy and four agencies receiving financial backing from NASA, which itself cannot directly cooperate with Chinese entities under U.S. law, according to Reuters. The Department of Health and Human Services also provided funding to help create 356 patents, more than any other agency.
It was not clear what specific projects were protected under the patents, according to Reuters. There was not an indication that the patents were funded by the U.S.-China Science and Technology Agreement, which is the framework deal penned in 1979 to jointly conduct research between the two countries.
The U.S.-China Science and Technology Agreement has fallen under scrutiny for allowing China to collaborate and glean from research that could help upgrade its military capabilities, according to Reuters. The deal expired in August, but has been given multiple extensions, with the latest extension having ended on Tuesday.
All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact [email protected].
" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."
*As an Amazon Associate I earn from qualifying purchases
Now loading...